Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a promising new target for the prevention of cardiovascular (CV) events. However, the clinical significance of circulating PCSK9 is unclear in hemodialysis (HD) patients. A total of 353 HD patients were prospectively enrolled from June 2016 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Hyeon Seok, Kim, Jin Sug, Kim, Yang Gyun, Lee, So-Young, Ahn, Shin Young, Lee, Hong Joo, Lee, Dong-Young, Lee, Sang Ho, Moon, Ju Young, Jeong, Kyung Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019341/
https://www.ncbi.nlm.nih.gov/pubmed/31963408
http://dx.doi.org/10.3390/jcm9010244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019341/
https://www.ncbi.nlm.nih.gov/pubmed/31963408
http://dx.doi.org/10.3390/jcm9010244

Ejemplares similares